ALBIREO PHARMA, INC.
DelistedCIK 1322505fmd_18M4A8800XD614PP9JM5V6WNR0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2004 to Sep 30, 2022, 55 periods
Latest annual · FY2021
Millions- Total revenues
- 41
- Gross profit
- 39
- Operating income
- (123)
- Net income
- (34)
- Free cash flow
- (108)
Latest quarter · Q3 FY2022
Millions- Total revenues
- 10
- Gross profit
- 9
- Operating income
- (35)
- Net income
- (38)
- Free cash flow
- (30)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +47.1%
- Revenue, 5 yearsFY2016 to FY2021
- n/m
- Net income, 5 yearsFY2016 to FY2021
- n/m
ALBIREO PHARMA, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $40.6 million | $8.3 million | +388.4% | 10-K 2022-03-01 · proof |
| Gross profit | $39.2 million | $8.3 million | +372.1% | 10-K 2022-03-01 · proof |
| Operating income | -$123.5 million | -$96.3 million | 10-K 2022-03-01 · proof | |
| Net income | -$34 million | -$107.6 million | 10-K 2022-03-01 · proof | |
| Cash from operating activities | -$107.6 million | -$101 million | 10-K 2022-03-01 · proof | |
| Free cash flow | -$108 million | -$101.1 million | 10-K 2022-03-01 · proof | |
| Total assets | $302.1 million | $285.6 million | +5.8% | 10-K 2022-03-01 · proof |
| Total liabilities | $126.4 million | $104.4 million | +21.1% | 10-K 2022-03-01 · proof |
| Cash and cash equivalents | $248.1 million | $251.3 million | -1.3% | 10-K 2022-03-01 · proof |
- What was ALBIREO PHARMA, INC.'s revenue in fiscal 2021?
- ALBIREO PHARMA, INC. reported revenue of $40.6 million for fiscal 2021 (the year ended Dec 31, 2021), against $8.3 million the year before (+388.4%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was ALBIREO PHARMA, INC.'s gross profit in fiscal 2021?
- ALBIREO PHARMA, INC. reported gross profit of $39.2 million for fiscal 2021 (the year ended Dec 31, 2021), against $8.3 million the year before (+372.1%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was ALBIREO PHARMA, INC.'s operating income in fiscal 2021?
- ALBIREO PHARMA, INC. reported operating income of -$123.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$96.3 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was ALBIREO PHARMA, INC.'s net income in fiscal 2021?
- ALBIREO PHARMA, INC. reported net income of -$34 million for fiscal 2021 (the year ended Dec 31, 2021), against -$107.6 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was ALBIREO PHARMA, INC.'s cash from operating activities in fiscal 2021?
- ALBIREO PHARMA, INC. reported cash from operating activities of -$107.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$101 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What was ALBIREO PHARMA, INC.'s free cash flow in fiscal 2021?
- ALBIREO PHARMA, INC. reported free cash flow of -$108 million for fiscal 2021 (the year ended Dec 31, 2021), against -$101.1 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are ALBIREO PHARMA, INC.'s total assets?
- As of Dec 31, 2021, ALBIREO PHARMA, INC. reported total assets of $302.1 million, against $285.6 million a year earlier (+5.8%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are ALBIREO PHARMA, INC.'s total liabilities?
- As of Dec 31, 2021, ALBIREO PHARMA, INC. reported total liabilities of $126.4 million, against $104.4 million a year earlier (+21.1%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
- What are ALBIREO PHARMA, INC.'s cash and cash equivalents?
- As of Dec 31, 2021, ALBIREO PHARMA, INC. reported cash and cash equivalents of $248.1 million, against $251.3 million a year earlier (-1.3%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1322505&period_type=annual&limit=5"Information only, not investment advice.